Ospedale San Paolo | ClinicalTrials HQ

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 2	2026-02-06		NCT04884282
AutoInflammatory Disease Alliance Registry (AIDA)	Behcet disease, Castleman disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Marshall syndrome, PFAPA syndrome, Schnitzler syndrome, Skin and Connective Tissue Diseases, Spondylarthritis, Stomatognathic Diseases, VEXAS syndrome, anterior uveitis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, cardiovascular disorder, connective tissue disorder, eye disorder, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, immunoproliferative disorder, juvenile idiopathic arthritis, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, monoclonal gammopathy of uncertain significance, mouth disorder, musculoskeletal system disorder, panuveitis, rheumatic disorder, scleral disorder, scleritis, skin disorder, skin vascular disease, spondylitis, systemic-onset juvenile idiopathic arthritis, uveal disorder, uveitis, vascular disorder, vasculitis, vertebral column disorder	Recruiting	Not stated	2025-07-10		NCT05200715